The effects of Provent on moderate to severe obstructive sleep apnoea during continuous positive airway pressure therapy withdrawal: a randomised controlled trial.

The effects of Provent on moderate to severe obstructive sleep apnoea during continuous positive airway pressure therapy withdrawal: a randomised controlled trial.

OBJECTIVES: The aim of this study was to test the effectiveness of Provent, an expiratory nasal resistance valve, to prevent the recurrence of OSA following CPAP withdrawal. DESIGN: Randomised, partially blinded, parallel, placebo-controlled trial. SETTING: Outpatient sleep clinics in the UK (Oxfor...

Bibliográfalaš dieđut
Váldodahkkit:	Rossi, V, Winter, B, Rahman, N, Yu, L, Fallon, J, Clarenbach, C, Bloch, K, Stradling, JR, Kohler, M
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	2013

Geahča maid

Return of sleep apnoea and sleep fragmentation following CPAP withdrawal in patients with obstructive sleep apnoea
Dahkki: Turnbull, C, et al.
Almmustuhtton: (2019)

Is continuous positive airway pressure necessarily an everyday therapy in patients with obstructive sleep apnoea?
Dahkki: Rossi, V, et al.
Almmustuhtton: (2014)

The role of the nose in the pathogenesis of obstructive sleep apnoea and snoring.
Dahkki: Kohler, M, et al.
Almmustuhtton: (2007)

Effects of obstructive sleep apnoea on heart rhythm.
Dahkki: Rossi, V, et al.
Almmustuhtton: (2013)

The effect of continuous positive airway pressure treatment on physical activity in patients with obstructive sleep apnoea: A randomised controlled trial.
Dahkki: West, S, et al.
Almmustuhtton: (2009)

Endothelial function in patients with mild moderate obstructive sleep apnoea
Dahkki: Kohler, M, et al.
Almmustuhtton: (2007)

Effects of continuous positive airway pressure on systemic inflammation in patients with moderate to severe obstructive sleep apnoea: a randomised controlled trial.
Dahkki: Kohler, M, et al.
Almmustuhtton: (2009)

Pharmacological approaches to the treatment of obstructive sleep apnoea.
Dahkki: Kohler, M, et al.
Almmustuhtton: (2009)

Effects of CPAP therapy withdrawal on exhaled breath pattern in obstructive sleep apnoea
Dahkki: Schwarz, EI, et al.
Almmustuhtton: (2015)

Obstructive sleep apnoea. Evidence for efficacy of continuous positive airways pressure is compelling.
Dahkki: Stradling, JR, et al.
Almmustuhtton: (1997)

Nocturnal cerebral hypoxia in obstructive sleep apnoea: a randomised controlled trial
Dahkki: Schwarz, E, et al.
Almmustuhtton: (2018)

Effects of CPAP therapy withdrawal on exhaled breath pattern in obstructive sleep apnoea
Dahkki: Stradling, J, et al.
Almmustuhtton: (2015)

Obstructive sleep apnoea and driving.
Dahkki: Stradling, JR
Almmustuhtton: (1989)

Obstructive sleep apnoea syndrome.
Dahkki: Stradling, JR
Almmustuhtton: (1982)

The effects of supplemental oxygen on blood pressure in obstructive sleep apnoea during cpap withdrawal
Dahkki: Turnbull, C, et al.
Almmustuhtton: (2017)

Effect of short term graded withdrawal of nasal continuous positive airway pressure on systemic blood pressure in patients with obstructive sleep apnoea.
Dahkki: Stradling, JR, et al.
Almmustuhtton: (1996)

The effect of obstructive sleep apnoea on hypoxic and inflammatory markers during CPAP withdrawal: Further evidence from three randomised control trials
Dahkki: Turnbull, C, et al.
Almmustuhtton: (2016)

Physiological consequences of CPAP therapy withdrawal in patients with obstructive sleep apnoea-An opportunity for an efficient experimental model
Dahkki: Schwarz, E, et al.
Almmustuhtton: (2018)

Period-to-period variability of moderate/severe obstructive sleep apnoea
Dahkki: Wigston, CA, et al.
Almmustuhtton: (2021)

Withdrawal of Continuous Positive Airway Pressure Therapy for 2 Weeks in Obstructive Sleep Apnoea Patients Results in Increased Circulating Platelet and Leucocyte-Derived Microvesicles.
Dahkki: Ayers, L, et al.
Almmustuhtton: (2016)

Withdrawal of continuous positive airway pressure therapy for 2 weeks in obstructive sleep apnoea patients results in increased circulating platelet and leucocyte-derived microvesicles
Dahkki: Ayers, L, et al.
Almmustuhtton: (2016)

Continuous positive airway pressure and liver enzymes in obstructive sleep apnoea: data from a randomized controlled trial.
Dahkki: Kohler, M, et al.
Almmustuhtton: (2009)

Continuous positive airway pressure treatment for obstructive sleep apnoea reduces resting heart rate but does not affect dysrhythmias: a randomised controlled trial.
Dahkki: Craig, S, et al.
Almmustuhtton: (2009)

Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial.
Dahkki: Jenkinson, C, et al.
Almmustuhtton: (1999)

Randomised, sham-placebo, parallel study of Nasal Continuous Positive Airway Pressure (NCPAP) for the treatment of Obstructive Sleep Apnoea (OSA)
Dahkki: Stradling, JR, et al.
Almmustuhtton: (1998)

Obstructive sleep apnoea.
Dahkki: Stradling, J
Almmustuhtton: (2007)

Is (re)titration of nasal continuous positive airway pressure for obstructive sleep apnoea necessary?
Dahkki: Choi, S, et al.
Almmustuhtton: (2001)

Obstructive sleep apnoea in adults.
Dahkki: West, S, et al.
Almmustuhtton: (2009)

Effects of continuous positive airway pressure therapy withdrawal in patients with obstructive sleep apnea: a randomized controlled trial.
Dahkki: Kohler, M, et al.
Almmustuhtton: (2011)

Effects of continuous positive airway pressure therapy withdrawal in patients with obstructive sleep apnea A randomized controlled trial
Dahkki: Kohler, M, et al.
Almmustuhtton: (2011)

Acute effects of obstructive sleep apnoea.
Dahkki: Davies, R, et al.
Almmustuhtton: (1993)

Randomised, sham placebo controlled study of nasal continuous positive airway pressure (NCPAP) on simulated steering in obstructive sleep apnoea (OSA).
Dahkki: Hack, M, et al.
Almmustuhtton: (1999)

Obstructive sleep apnoea - Reply
Dahkki: Stradling, JR, et al.
Almmustuhtton: (1999)

Pitfalls of clinical trials on pharmacological treatment for obstructive sleep apnoea: future directions.
Dahkki: Kohler, M, et al.
Almmustuhtton: (2011)

Night-to-night variability of obstructive sleep apnoea
Dahkki: Stoberl, A, et al.
Almmustuhtton: (2017)

The phenotype of obstructive sleep apnoea
Dahkki: Stradling, J
Almmustuhtton: (2008)

Driving and obstructive sleep apnoea.
Dahkki: Stradling, J
Almmustuhtton: (2008)

Endocrine effects of nasal continuous positive airway pressure in male patients with obstructive sleep apnoea.
Dahkki: Meston, N, et al.
Almmustuhtton: (2003)

Continuous positive airway pressure in older people with obstructive sleep apnoea syndrome (PREDICT): A 12-month, multicentre, randomised trial
Dahkki: McMillan, A, et al.
Almmustuhtton: (2014)

Quality of life before and after Nasal Continuous Positive Airway Pressure (NCPAP) treatment for Obstructive Sleep Apnoea (OSA)
Dahkki: Stradling, JR, et al.
Almmustuhtton: (1996)